Publicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (9)

2024

  1. A new BRAF inhibitor breaks resistance barriers

    Trends in Cancer

2023

  1. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve

    Circulation, Vol. 147, Núm. 1, pp. 47-65

  2. TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma

    Arthritis Research and Therapy, Vol. 25, Núm. 1

2022

  1. Inflammation in Health and Disease: New Insights and Therapeutic Avenues

    International Journal of Molecular Sciences

2019

  1. Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: Data from the Osteoarthritis Initiative

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 12, pp. 1699-1705

2017

  1. A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1350-1357

  2. Screening and Validation of Novel Biomarkers in Osteoarticular Pathologies by Comprehensive Combination of Protein Array Technologies

    Journal of Proteome Research, Vol. 16, Núm. 5, pp. 1890-1899

2014

  1. Emerging Nanotechniques in Proteomics

    Comprehensive Analytical Chemistry (Elsevier B.V.), pp. 137-157

2008

  1. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer

    Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814